NORDIC Nordic Congress 2020 Brochure.pdftechnology innovators driving the future of healthcare. Now...
Transcript of NORDIC Nordic Congress 2020 Brochure.pdftechnology innovators driving the future of healthcare. Now...
Live and on-demandpanels
Thought leadership opportunities
Strategy, investment & networking
Access to a mix of live and on-demand content
1-4 September 2020
3rd Annual Conference
www.lsxleaders.com/nordic #lsxnordic @lsxleaders
Created by
STRATEGY, I NVESTMENT, PARTNERING AND DEAL M AKING FOR L IFE SC IENCE
EX ECUTIVE LEADERS
NORDICCONGRESS
VIRTUAL
LSX Nordic Congress 1-4 September 2020
www.lsxleaders.com/nordic
The LSX Nordic Congress is a high-calibre, senior executive conference and partnering event designed to bring international investment and strategic partners for Nordic life companies to the region. The Nordic region has long produced world-leading science and innovation and the LSX Nordic Congress will be all about showcasing this innovation, both of the region’s industry leaders but also through start-ups and technology innovators driving the future of healthcare. Now in its third year, and delivered digitally, the online experience features everything from the physical event and more! Hear from, connect, network and schedule 1:1 meetings with the leading lights and most exciting startups in life sciences from across the Nordics, as well as global investors and partners!
LSX Nordic Congress VirtualWhat is it and who is it for?
What is a virtual experience?
LSX Nordic Congress 1-4 September 2020
www.lsxleaders.com/nordic
Social distancing practices around the world have shown just howproductive digital work methods can be, and we are confident LSX Nordic Congress Virtual will deliver equal if not even greater, value as attending the physical event.
Across four days you’ll be able to:
• Access a mixture of live interactive panels and on-demand debates and discussions; dip in and out of the content sessions and watch at times that suit your partnering schedules so you never miss a thing.
• Schedule and take 1:1 video meetings and network with hundreds of Nordic life science executives, global and investors and partners from the comfort of your office or home workspace.
• Participate in live interactive forums with your peers and expert-led workshops!
• Dive into an exciting library of company showcases from the most innovative life sciences companies and budding startups
Don’t just think of it as an online physical event, think of it as a brand-new virtual experience!
LSX Nordic Congress Virtual offers three different content formats in which enjoy the sessions on offer: LIVE = Real-time content with audience Q&A (becomes on-demand once held)
ON-DEMAND = Evergreen content that can be watched anytime to fit around your schedule
INTERACTIVE = Live, peer-to-peer grouped sessions allowing multi-way discussion
Key SpeakersLSX Nordic Congress 1-4 September 2020
www.lsxleaders.com/nordic
Ingrid Akay Managing PartnerHadean Ventures
Adam Kostyál SVP, Nasdaq
Phil L’HullierHead of BD, Europe, European Innovation HubMSD
Thierry Laugel Managing PartnerKurma Partners
Andreas Jurgeit Partner,Lundbeckfonden
Stephan Christgau Partner,Eir Ventures
Patrik SobockiInvestment ManagerIndustrifonden
Klaus Stöckemann Managing PartnerPeppermint Venture Partners
Karl XavierPartnerAxilium Capital
Sascha Alilovic Partner, SHS
Gunilla Osswald CEO, BioArctic
Don deBethizy Director, Argenx
Karl Bergman CEO, Elypta
Martin Åmark CEO, Xbrane Biopharma
Carsten Borring AVP, Listings EMEA and Head of Listings & Capital Markets, NASDAQ
Ingalill Hyltander Commercial Operation Director Pharma Scandinavia, Bayer
Maria Tell Investment Manager, Almi Invest
Mats Berggren Director, Digital Business Innovation & External Collaboration Models, M-Digital Lead, Merck KGaA
Nikolaj Sørensen CEO, Orexo
Ulrica Slåne Bjerke CIO, Arctic Aurora LifeScience
Carsten Kjær Joensen Head of Office for Life Sciences, Government Offices of Denmark
Magnus Corfitzen CEO, Ascelia Pharma
Renée Aguiar-Lucander CEO, Calliditas Therapeutics
Jenni NordborgHead of the Office for Life Sciences, Government Offices Sweden
LSX Nordic Congress 1-4 September 2020
www.lsxleaders.com/nordic
Congress PartnersHost Sponsor
Gold Sponsors
Media & Supporting Partners
Silver Sponsors
Associate Partners
Bronze Sponsors
Thomas Lönngren Strategy Advisor, NDA Group and former Head of EMA
Agenda at a glance1-4 September 2020LSX Nordic Congress
www.lsxleaders.com/nordic
Agenda at a glance1-4 September 2020LSX Nordic Congress
www.lsxleaders.com/nordic
LIVE: KEYNOTE ADDRESS–THE FUTURE OF DANISH LIFE SCIENCES STRATEGY
09:05
LIVE: PUBLIC CEO FORUM
ON DEMAND PANEL: WHAT’S HOT IN EARLY STAGE INVESTMENT?
1:1 PARTNERING (available all-day)
LIVE KEYNOTE PANEL: COMING OUT THE OTHER SIDE: PERSPECTIVES ON LIFE SCIENCE STRATEGIES, PRIVATE AND PUBLIC FINANCING, PARTNERSHIPS AND M&A IN THE AFTERMATH POST-COVID-19
Day 1 Day 2
11:00
13:00
LIVE PANEL: GLOBAL SYNDICATION AND EXPANDING YOUR INTERNATIONAL INVESTOR BASE
16:00
CLOSE16:45
ON DEMAND KEYNOTE PANEL: INVESTING IN HEALTHTECH & DIGITAL HEALTH - THE NEXT WAVE OF NORDIC INNOVATION
Day 3 Day 4
11:00
ON-DEMAND SHOWCASES (available all-day)09:00
10:30
LIVE: PRIVATE CEO FORUM (1 hr 45 mins)14:00
09:15
16:00
16:45
PRESENTATION: DEVELOPMENT WITH THE END IN MIND - HOW TO BRIDGE THE “VALLEY OF DEATH”
10:15
12:45DRIVING SHAREHOLDER VALUE THROUGH EFFECTIVE PARTNERSHIPS
LIVE: DEVELOPING AND OPTIMISING PHARMA PARTNERSHIPS ACROSS BIOTECH, MEDTECH AND HEALTHTECH INNOVATION
CLOSE
1:1 PARTNERING (available all-day)10:00
1:1 PARTNERING (available all-day)
ON DEMAND: ALL PANELS (available all-day)
ON-DEMAND SHOWCASES (available all-day)
09:00
1:1 PARTNERING (available all-day)
ON DEMAND: ALL PANELS (available all-day)
ON-DEMAND SHOWCASES (available all-day)
09:00
09:0009:00
09:00 09:00
*All times in CEST (GMT - 1hr)
*All times in CEST (GMT - 1hr)
LIVE: KEYNOTE ADDRESS – THE FUTURE OF SWEDISH LIFE SCIENCES STRATEGY
09:20
LIVE: JOINT Q&A09:35
LIVE: OPENING PANEL:CULTIVATING A SUSTAINABLE ECOSYSTEM AND COMPANIES WITH LONG-TERM AMBITIONS IN THE NORDICS
10:00
15:00LIVE: DEVELOPING AND OPTIMISING PHARMA PARTNERSHIPS ACROSS BIOTECH, MEDTECH AND HEALTHTECH INNOVATION
2020 Investors & Pharma BDLSX Nordic Congress 1-4 September 2020
www.lsxleaders.com/nordic
INVENTING FOR LIFE
2020 Investors & Pharma BDLSX Nordic Congress 1-4 September 2020
www.lsxleaders.com/nordic
Full Agenda1-4 September 2020LSX Nordic Congress
www.lsxleaders.com/nordic
11:00LIVE: Public CEO Forum (Zoom)
Co-hosted by:
Moderator: Don deBethizy, Director, Argenx
Nordic and Global Capital Market Outlook Adam Kostyal, SVP, Head of European Listings, Nasdaq Peter Legind-Hansen, MD, Nasdaq
Conference - 1 September09:00
LSX & Nasdaq Welcome Josh Dance, SVP, LSX Adam Kostyál, SVP, Nasdaq
10:00LIVE: Opening Panel: Cultivating a sustainable ecosystem and companies with long-term ambitions in the Nordics Key stakeholders from across the region discuss how the Nordic ecosystem is evolving and what more can be done to finance, invest and build the Nordic cluster with a great proportion of larger companies with long-term ambitions, to complement and support the thriving startup and growth stage community.
• What does it take to build large and internationally competitive companies? Do enough have the long-term ambitions?• Which policy, regulation and industry initiatives can help build upon the exceptional life science leadership and innovation and work towards an even more internationally competitive hub and the growth of $billion businesses?• How, and in which ways, can Government strategy and support help shape and build the Nordic life sciences cluster?• What are the key success factors for companies in internationalisation and finding global investors, partners and advisors?
Moderator: Bobby Soni, CBO, Novo Nordisk BII Nikolaj Sørensen, CEO, Orexo Magnus Corfitzen, CEO, Ascelia Pharma Jenni Nordborg, Head of the Office for Life Sciences, Government Offices of Sweden Adam Kostyál, SVP, Nasdaq
LIVE: Keynote Address – The Future of Danish Life Science Strategy • Providing an update on the 2018 Life Sciences Growth Plan• Progress on the 36 initiatives put in place to target barriers and capitalise on opportunities across the value chain for the Danish Life Sciences Industry across the value chain• How and in what ways has the covid-19 pandemic affected the sector?
Carsten Kjær Joensen, Head of the Office for Life Sciences, Government Offices of Denmark
09:05
LIVE: Keynote Address – The Future of Swedish Life Science Strategy • Outlining the core components of the new Life Sciences Strategy• How will Sweden work to attract and maintain life science companies and strengthen home-grown companies’ abilities to grow and meet global healthcare demands?• How and in what ways will the new strategy and roadmap be implemented?
Jenni Nordborg, Head of the Office for Life Sciences, Government Offices of Sweden
09:20
LIVE: Joint Q&A Carsten Kjær Joensen, Head of the Office for Life Sciences, Government Offices of Denmark Jenni Nordborg, Head of the Office for Life Sciences, Government Offices of Sweden Josh Dance, SVP, LSX
09:35
Pre-Day IPO Bootcamp1-4 September 2020LSX Nordic Congress
www.lsxleaders.com/nordic
LIVE: THE CURRENT STATE OF THE NORDIC IPO MARKET09:00
LIVE ROUNDTABLE: DETERMINING AND DEFINING YOUR IPO STRATEGY
IPO CASE STUDY Magnus Corfitzen, CEO, Ascelia Pharma
1:1 EXPERT CONSULTATIONS: OVER ZOOM CALLS
09:20
10:00
CLOSE17:00
11:00
In line with our mission to support funding, financing and deal making in the sector, LSX teaming up with some of the regions foremost experts, advisers, bankers and consultants to help CEOs and CFOs navigate the how, what, where and when of a successful IPO on Nasdaq Nordics. The Bootcamp runs as part of the 3rd annual LSX Nordic Congress, delivered virtually.
The Nordic IPO Bootcamp is an invitation only online forum, workshop, and series of digital 1-2-1 video meetings. It provides CEOs and CFOs of life science companies contemplating an IPO a unique opportunity to come together for a series of frank and open discussions with peers, case studies from executives who have recently been through the process, and for tailored and 1-2-1 advice with the region’s foremost experts, advisers, bankers and consultants.
*Bootcamp by invitation only. If you are interested in a seat at the bootcamp message [email protected]
*All times in CEST (GMT - 1hr)
Co-hosted by:
Keynote Panel: Investing in Healthtech & Digital Health - The next wave of Nordic innovation Healthtech and digital health technologies are starting to realise their promise and make meaningful impacts across the life science and healthcare space, and the Nordic countries are among Europe’s leaders in the digital healthcare revolution. Investors and executives discuss the local and international investment landscape in digital and health technology and how the Nordics can lead the way in innovation.
• How quickly could Nordic healthtech innovation grow to match medtech and biotech expertise?• The region already boasts some exciting digital health success stories; is innovation in this area continuing to grow and how are investors seeing digital investment opportunities compared to more traditional investments?• The covid-19 epidemic has expedited the digitisation the healthcare sector and validated its necessity; how are investors evaluating these opportunities as necessity in which specific technologies has the acceleration been most evident, and how do you pick the future winners? Moderator: Kathrine Myhre, CEO, Norway Health Tech Patrik Sobocki, Investment Manager, Industrifonden Klaus Stöckemann, Managing Partner, Peppermint VP Andreas Lindblom, CEO, Sciety
11:00
Full Agenda1-4 September 2020LSX Nordic Congress
Conference - 2 September
www.lsxleaders.com/nordic
12:45Driving shareholder value through effective partnerships Partnering up with big pharma or other life science companies can make cost savings and pool resources and expertise, but for public companies are not without risk. Executives of public companies with licencing, co-development and R&D partnerships share their stories of securing these deals and discuss effective deal structures, mitigating risks in asset dilution and commercialisation rights and how to drive shareholder value through optimising these partnerships.
• Balancing partnerships with further capital raises for pipeline development; what are the long term affects on stock price?• What are the most effective deal structures for public companies entering partnerships?• How can you ensure deals are transformative for company growth whilst retaining value for shareholders? Moderator: Jan de Kerpel, Managing Director, Kempen Gunilla Osswald, CEO, BioArcticDon deBethizy, Director, Argenx Renée Aguiar-Lucander, CEO, Calliditas Therapeutics
Full Agenda1-4 September 2020LSX Nordic Congress
www.lsxleaders.com/nordic
16:00LIVE: Developing and optimising pharma partnerships across biotech, medtech and healthtech innovation
The potentially transformative nature of partnership a big pharma is well documented but is not without its risks and challenges and partnerships and deals differ between private and public companies. Pharma continue to be hungry to source innovation and build win-win partnerships with the latest technologies to supplement and complement internal R&D. Heads of innovation, search and evaluation and business development from big Pharma discuss the role pharma companies are taking in supporting younger companies and the evolving strategies in all life science and technology partnerships and deals.
• Will the trend of private rounds in place of IPOs in Europe for European companies continue?• Will increasing interest from American and Asian funds lead to more competitive tension for deals in Europe? • How can companies, and how will investors, be getting out and connecting internationally in the new normal? Moderator: Thomas Lönngren, Strategy Advisor, NDA Group and former Head of EMAPhil L’Huillier, Head of BD, Europe, European Innovation Hub, MSD Ingalill Hyltander, Commercial Operation Director Pharma Scandinavia, BayerMats Berggren, Director, Digital Business Innovation & External Collaboration Models, M-Digital Lead, Merck KGaA Nerida Scott, Head of Johnson & Johnson Innovation EMEA, Johnson & Johnson
16:45Close of Day 2 Content - Partnering Continues
13:00What’s hot in early stage investment? Expert early-stage investors highlight where they see the exciting and hot new areas in life sciences investment. They will also debate how smaller can compete with larger funds dominating increasingly larger series A rounds, and if we see an even greater focus on early syndication from smaller players, particularly post-covid. • The Nordic early-stage startup ecosystem is booming–in which areas is there most excited and where is the early capital currently going? • How are smaller funds competing with larger local and international funds? Will we see ever greater syndication in early deals? • Is there enough support and local capital for early-stage innovation to be funded and thrive? Karl Xavier, Partner, Axilium CapitalAndreas Jurgeit, Partner, Lundbeckfonden Emerge Ingrid Akay, Managing Partner, Hadean Ventures Maria Tell, Investment Manager, Life Sciences, Almi Invest
14:00LIVE: Private CEO Forum (Zoom)
Co-hosted by:
Conference - 1 September
16:00LIVE: Panel: Global syndication and expanding your international investor base
With new Nordic and European life science funds emerging, long term specialists recharging and new players and capital from Asia and the Middle East, as well as the US, increasingly entering into deals, global syndication in the healthcare space is reforming the investment landscape. Investors discuss how the Nordic region, as a leading European hub for new science and innovation, and the companies from it can access, build and leverage an international investor base.
• Will the trend of private rounds in place of IPOs in Europe for European companies continue? Do the strong Nordic public markets factor into investment decisions?• Will increasing interest from American and Asian funds lead to more competitive tension for deals in Europe?• How can companies, and how will investors, be getting out and connecting internationally in the new normal?
Moderator: John Rudy, Member, MintzStephan Christgau, Partner, Eir Ventures Rachel Mears, Partner, Jeito Thierry Laugel, Managing Partner, Kurma Partners Sascha Alilovic, Managing Partner, SHS Petros Farah, Vice President, Vickers Venture Partners
16:45Close of Day 1 & Virtual Drinks - Partnering Continues
09:15LIVE: Keynote Panel: Coming out the other side: Perspectives on life science strategies, private and public financing partnerships and M&A in the aftermath post-Covid-19 The COVID-19 outbreak has sent shockwaves through the world, disrupting every industry and creating uncertainties in financial markets. The life sciences and healthcare is in a unique position with some companies pivoting to help in the fight against the virus, others business plans being severely disrupted, and both public and private investors in the sector navigating an untrodden path. A cross-stakeholder panel discusses • What has been the impact on investors portfolio companies, investment strategies and appetite in the short and medium term?• How and where will changes in the public and private capital available to companies affect wider industry M&A activity?• Could Pharma partnering strategies change? How can companies best position themselves to come out stronger? Moderator: Chris Maggos, Managing Director, Head of Europe, LifeSci Advisors Ulrica Slåne Bjerke, CIO, Arctic Aurora LifeScience Benedicte Bakke, Portfolio Manager, DNB Asset Management Søren Moller, Managing Director, Novo Seeds Mario Augusto Maia, Head of Investments, Novozymes
Case Studies
Nordic and Global Capital Market Outlook Adam Kostyal, SVP, Head of European Listings, Nasdaq Peter Legind-Hansen, MD, Nasdaq Accessing US Capital & Partners Chris Jeffers, Member, Mintz Raising Capital During COVID-19 Patric Stenberg, CEO, Gesynta
11:00LIVE: Public CEO Forum (Zoom)
Co-hosted by:
Key Legal Trends and Highlights Erik Sjöman, Partner, Vinge Dain Hård Nevonen, Partner, Vinge Biotech Going Digital Nikolaj Sørensen, CEO, Orexo
10:15Presentation: Development with the end in mind - how to bridge the “valley of death” • Common threats for a startups and how to mitigate them• Developing an integrated strategy for efficient pharmaceutical development• Strategies to bridge the valley of death Anders Nyholm, Director Life Science Consulting, ProPharma Group
15:00LIVE: Nasdaq Nordic listing and cross trading on the US OTC Markets: Creating a global trading solution for investors and opportunity for Nordic companies Reaching American investors is usually always a big focus for life sciences companies, be that for private or public investments. What are the best strategies for gaining access and exposure to American capital? The panel discusses:
• When should a company consider cross-trading on the US OTC Markets?• How does OTC Markets and Nasdaq Nordics businesses complement each other and what does this mean for Nordic issuers?• What are the benefits of gaining access and exposure to American investors through the secondary US OTC market?• From the company perspective, what can this exposure mean for your business? How can cross trading increase volume and liquidity on the local exchange due to greater access to US investors? Moderator: Joe Coveney, Vice President, OTC MarketsLena Wange, Head of Investor Relations, OrexoAdam Kostyal, SVP, Nasdaq
Full Agenda1-4 September 2020LSX Nordic Congress
www.lsxleaders.com/nordic
Conference - 3 September
Conference - 4 September
All live and on-demand panels available on-demand
1:1 Partnering (All Day) On Demand Showcase Videos (All Day)
ALL DAY
All live and on-demand panels available on-demand
1:1 Partnering (All Day) On Demand Showcase Videos (All Day)
ALL DAY
To maximise the opportunity for international 1:1 partnering in the virtual format, across multiple timezones and working around work commitments and schedules, the event and partnering system will remain live for the full week! What’s more, to ensure you have the chance to view all of the panel discussions, keynote sessions and showcases of the most exciting and innovative companies the Nordic region has to offer, these will all be available on-demand for the rest of the week too!
ShowcasesLSX Nordic Congress 1-4 September 2020
www.lsxleaders.com/nordic
The virtual experience showcases all stages of private and public biotech, medtech and healthtech companies from across the Nordic Region.
Companies have the opportunity to pre-record and release on-demand video showcases alongside their profiles and relevant supporting documentation for investors and partners to search, evaluate and connect. Showcases will remain available on-demand for the full four-day experience.
Companies have the opportunity to utilise a virtual booth to stream / broadcast additional content that sits along side live chat functionality to help demonstrate products/technology in realtime.
When is showcasing and a virtual tech booth a good idea:
• When you are actively fundraising or looking to attract partners• When you have impactful company or product news• When you are raising awareness of your business or new developments in your pipeline or
commercial development
Confirmed ShowcasesLSX Nordic Congress 1-4 September 2020
www.lsxleaders.com/nordic
1:1 PartneringLSX Nordic Congress 1-4 September 2020
www.lsxleaders.com/nordic
LSX is committed to foster collaboration among all virtual conference attendees. Our goal is for you to establish new partnerships, and find the best connections possible even when face-to-face is not possible.
Video and audio-enabled partnering is delivered through this web-based content platform which allows the pre-arrangement of video-conference meetings 2 weeks from the event and for the duration of the four days.
Swapcard is an powerful AI-driven matchmaking platform, meaning the stress of finding likeminded executives is removed when using this automated software. Complete your profile in full and Swapcard will AI-match with registered delegates, presenting you with a rated list of executives aligned to your search criteria from most relevant to least relevant. You can still search the full list of participants alongside this automated process should you wish to expand your outreach to other profiles.
Registered attendees will be able to access their own personal schedule, search attendees’ profiles, request and reschedule meetings with other executives and connect for private and secure 20min video conferencing.1:1 Partnering runs 24hrs to accommodate all time zones and kicks off from 10am CET on Day 1. We also realise that some of the most valuable connections happen through serendipitous and chance meetings. For this reason there will be several dedicated networking receptions built in to the virtual schedule each day allowing you to engage in live text chat or 3min speed networking-style video calls with other online attendees, before deciding if you’d like to arrange a more formal meeting through the partnering system.
1-4 September 2020LSX Nordic Congress
www.lsxleaders.com/nordic
2019 Attendee BreakdownThe LSX Nordic Congress grow significantly in the second year, in terms of the overall numbers and diversity of the delegation, the international investor attendance, and with a showcase of some of the most exciting life science and healthcare companies the region has to offer; from the newest innovative start-ups to the region’s leading public corporates.
These stats highlight the diversity of the audience.
1-4 September 2020LSX Nordic Congress
www.lsxleaders.com/nordic
2019 Companies Breakdown
86%
4%5% 5%
Company Attendee Seniority
C-Level / President / Board Level / Founder
SVP / EVP / VP
Head / Manager
Director
1-4 September 2020LSX Nordic Congress
www.lsxleaders.com/nordic
2019 Investor Breakdown 2019 Attendee Summary
LSX Nordic Congress 1-4 September, 2020
www.lsxleaders.com/nordic
Chief Executive Officer, 2A PharmaChief Business Officer, 2cureXChief Operating Officer, 2N PharmaPartner, 4BIO CapitalInvestment Director, 4BIO CapitalCEO, A1M Pharma COO, Aasa Health AB - “Träning på Recept”Partner, ABG Sundial ColliarCEO, AblyCEO, AbomicsCEO, Active BiotechAngel, ActivebizCEO, AddBIOChairman, AddBIOPartner, Advokatfirman DelphiCEO, AffibodyCEO, Age LabsInvestment Manager, Almi InvestSenior Financial Advisors, Alpha Blue OceanChief Executive Officer, Annexin PharmaceuticalsCSO, AnoccaChief Executive Officer & Scientific Founder, AnoccaCEO, AplagonCEO, ApoglyxFounder, PM, ArcticChief Executive Officer, ArocellChief Executive Officer, Ascelia PharmaFounder and CEO, Asgard TherapeuticsCEO, AtrogiCFO, Avia PharmaPartner European Patent Attorney, AWA SwedenCEO, AZ BioVentureHubFounding Partner, BedrockCEO, BerGenBioCOO, Biomedical BondingCEO, Biomedical BondingCEO, BiomodicsCEO, Bioservo TechnologiesCEO / EDITOR, BioStockCEO, BrainCoolPrincipal, Bridge Valley VenturesCEO, Calliditas TherapeuticsChief Executive Officer, CantargiaCEO, CardiaccsDirector, Business Development, CelerionCo founder + CFO, CerenionCEO, Cereno ScientificDirector of Business Development, Clinical Reserach Services Turku-CRSTCEO, CLSproject manager, Connect UppsalaClient Partner, Coulter PartnersCEO, CytovacCEO, DesentumPresident & CEO, Diamyd MedicalCFO, Diamyd MedicalCEO, DicotBoard Member, DicotCEO, DilaforChief Commercial Officer, Dyadic InternationalChief Executive Officer, Elypta
CEO, Endovascular DevelopmentManaging Director, EstBANCEO, EVMPartner, Head of Corporate Finance and Life Sciences Nordics, EYPartner, EYVP, Financing and Investor Relations, Faron PharmaceuticalsAssociate, ForbionCEO, Gedea BiotechCEO, Genagon TherapeuticsChief Operating Officer, Genagon TherapeuticsSenior Investment Manager / Vice President Business Development, Global Core MedicalChief Executive Officer, GlucoSetNational Coordinator Life Sciences, Government Offices of SwedenDigital Media Director, Guided SolutionsCEO, Guided SolutionsManaging Partner, Hadean VenturesPartner, Hadean VenturesPartner, HBM PartnersPartner, HealthCapInvestment Associate, HealthCapChief Executive Officer, Herantis Pharma PlcPatent Director, HGFCEO, Hy5Associate, Illumina VenturesCEO, ImmunicumChief Executive Officer, ImmunoviaCEO, ImmunscapeInvestment Manager, IndustrifondenVenture investor, IndustrifondenCEO, InfiCure BioDirector of Innovation, Innovation SkaneCEO, Inorbit Therapeutics abInvestment Director, InventureInvestment Director, InvestinorSenior Associate, InvestinorPartner, IPF PartnersBusiness Development Director, IQVIAAssociate Director, IQVIABD Director, IQVIAGeneral Partner, Joint Polish Investment fundGeneral Partner and Chairman, JulzAngel, Karolina VenturesDirector, Kempen CEO, KIRAMVice President, Kreos CapitalFounder, Ktisis BioDirector, LavivoCEO, LavivoCEO, Lind Growth StrategyCEO, Longboat AmnioticsExecutive Vice President, LU HoldingPortfolio Manager, LU HoldingConsultant, LucyJRobertshawPartner, Lundbeckfonden EmergeCEO, LyfstonePartner, MAKI.VCCEO, Meabco
2019 Attendee SummaryLSX Nordic Congress 1-4 September, 2020
www.lsxleaders.com/nordic
CSO, MeabcoCEO, MedbeatChief Executive Officer, MedeonPresident, MedVASCHealthcare Reporter, MergermarketCo-chair, Life Sciences Practice Group, Mintz Levin Cohn, Ferris, Glovsky and Popeo, P.C.CEO, Modus TherapeuticsVD, Monica Hedberg InvestCEO, MonidorExecutive Director, Oncology, MSDInvestment Partner, MTIPEuropean BD&L Manager, MundipharmaSenior Managing Director EMEA, NasdaqDirector, NasdaqStrategy Advisor, NDA GroupCEO, Nordic NanovectorHead of Communication, Norway HealthtechManaging Partner, Novo Seeds, Novo HoldingsAssociate, Novo HoldingsVP of Search & Evaluation, Novo NordiskCEO, NuevolutionCBO, deputy CEO, Oasmia PharmaceuticalsCEO, OcusweepCEO, OmnioCEO & Founder, Oncology VentureChief Operating Officer, Oncology VentureVP Business Development, Oncology VentureChief Executive Officer, OnDosisDirector, Optimum Strategic CommunicationsPrincipal, Optum VenturesCEO, OtivioCEO, PanCryosCCO, Particle3DCEO, Particle3DCTO, Particle3DEuropean Lead Worldwide Business Development, PfizerPartner, Potter ClarksonAssociate, Potter ClarksonSenior PPD Consulting Director, PPDSenior Account Director, PPDCFO, Primex PharmaceuticalsGroup CEO, Primex PharmaceuticalsCEO, ProkariumFounder, R VenturesChairman of the Board, Reccan DiagnosticsEVP, Red Glead DiscoveryCEO, Resorbable DevicesCEO, ResoTher Pharma ApSCEO, RespinorCBO & Deputy CEO, RhoVacPM, RhoVacFounding Director, Rigi CareCEO, SAGA DiagnosticsDirector, Finance, SAGA DiagnosticsChair, Board of Directors, SanionaCFO, Saniona
Partner, Sarsia FundManaging Director, SBA Ltd (on behalf i2020 Accelerator)CEO, Scandion OncologyCEO, ScietyInvestment Manager, ScietyHead of Equity Sales, Sedermera FondkommissionChairman, SenzagenChief Executive Officer, SenzagenPartner, Serendipity partnersCOO, Serodus ASAChief Executive Officer, Serodus ASAPartner, SHS CapitalBusiness Development, SmiLe IncubatorManaging Partner, Sofinnova PartnersCEO, Spago NanomedicalProgramme and Partnerships Manager, Start CodonStartUp Health Ambassador, Europe & Israel, StartUp Health IncManaging Director, StifelCEO, SubcujectManaging General Partner, Sunstone Life Science VenturesCEO & Co-Founder, Surgify MedicalPM, Swedbank RoburChief Executive Officer, Swedish Orphan BiovitrumHead of Communications, Swedish Orphan BiovitruviumManager Swelife International, SwelifePA to CEO, SymphogenChief Executive Officer, Symphogen Sr Director Business Development, SynteractInvestment Manager, TesiCEO, TFSAnalyst, TillväxtanalysPrincipal, Europe, TRINITY Life SciencesCEO, UmanSenseBusiness coach, Umeå Biotech IncubatorAngel, Uppsala BiotechSenior Advisor, Uppsala Innovation CentreCEO, Uppsala universitet HoldingInvestment director, VækstfondenCBO, Valo TherapeuticsHead of R&D, Valo TherapeuticsChief Operating Officer, VAR2 PharmaceuticalsChief Executive Officer, VetokCFO, Vicore PharmaChief Executive Officer, Vicore PharmaPartner, VingePartner, VingePartner, Vitality in Aging Research GroupChief Executive Officer, Xbrane BiopharmaChief of innovation division, Zcube - Zambon research ventureCEO, Zora BiosciencesCOO, Zora Biosciences
1-4 September 2020LSX Nordic Congress
www.lsxleaders.com/nordic
Why Sponsor
For sponsor or exhibition enquiries contact:
Joe Knight, BD Manager, [email protected]
+44 (0) 20 7039 3408
The LSX Nordic Congress Virtual experience offers a limited number of opportunities for companies wishing to raise their profile, enhance their brand, demonstrate thought leadership and access and engage with leaders in Nordic life sciences and global investors and partners
We are presenting tremendous opportunities for top tier service companies who would see the congress as a platform to:
• Demonstrate thought leadership and position your organisation at the forefront of the exciting Nordic life sciences ecosystem
• Educate potential new clients and partners about your unique offering, service or solution
• Generate qualified business leads through bespoke, forums with high-calibre life science decision makers
• Be seen as an obvious partner of choice in your specified domain as this market grows
What can sponsorship of a virtual experience offer that a physical event cannot? • Reporting and tracking; receive stats and intel on who and how many engaged with your session / content through the four-day experience and beyond
• Longer interaction and more impressions; the virtual experience gives an additional 30-days of exposure to all content, meaning your sessions / content reach a far wider audience than just those present the day the experience was live
• A larger geographical pool of prospects; there will always be time limitations as to how many delegates can attend a physical event, a virtual event is more accessible
• Halve your costs; removing flight, hotel and subsistence costs from your budget massively reduces your budgetary spend and saves you time meaning you are more productive
1-4 September 2020LSX Nordic Congress
Delegate Packages
www.lsxleaders.com/nordic
For delegate enquiries contact:
Joe Knight, BD Manager, [email protected]
+44 (0) 20 7039 3408
14-Aug
Free
7600
FullPrice
2500
8900
Industry Tickets
Content Only Ticket
Investor Ticket + 1:1 Partnering
All...Tech Ticket + 1:1 Partnering
All...Tech Ticket + 1:1 Partnering+ Showcase + Virtual Tech Demo Booth Pharma Ticket + 1:1 Partnering
All Services Ticket + 1:1 Partnering
26-Jun 24-Jul
Free
5000
Free
6400
All prices are displayed in Swedish Krone (SEK).
7600 89005000 6300
11400 127008900 10100
11400 127008900 10100
Leading life science events1-4 September 2020LSX Nordic Congress
Free FreeFree Free
• Watch all the talks and panel discussions; Sessions are available to registered attendees live via an interactive experience and On-Demand
• Schedule 1:1 video partnering throughout the week with all attendees
• Join CEO Virtual Forums with your peers and workshops with industry experts
• The opportunity to record and deliver an online showcase to raise your company’s profile • Connect with attendees through live chat conversations
• Resources, reports and speaker presentations available for download
Pass Benefits
2-3 February 2021, 133 Houndsditch, London, UK www.lsxleaders.com/healthtech-leaders-2021
WORLDCONGRESS
2-3 February 2021, 133 Houndsditch, London, UK www.lsxleaders.com/world
5-6 May 2021, Business Design Centre, London, UK www.lsxleaders.com/healthspan
5-6 May 2021, Business Design Centre, London, UK
15-18 September 2020 Virtual Event www.lsxleaders.com/healthtech
HEALTHT CH LEADERSVIRTUAL PARTNERING & INVESTMENT
Contact us today to find out how to get involved in any or all of our events. www.lsxleaders.com/events
11-16 November 2020 Virtual Event www.lsxleaders.com/investival
Live and on-demandpanels
Thought leadership opportunities
Strategy, investment & networking
Access to a mix of live and on-demand content
Contact Us
For speaker opportunities contact:
Josh Dance, [email protected] +44 (0)20 7039 3403
For sponsor and booking opportunities contact:
Joe Knight, BD [email protected] +44 (0)20 7039 3408
For press, media & marketing enquiries contact:
Paul Gilbertson, Marketing [email protected] +44 (0)20 7039 3405
Or visit us at www.lsxleaders.com/nordic
www.lsxleaders.com/nordic #lsxnordic @lsxleaders
Created by